Ibritumomab Intravenous and K-Effervescent Tablets
Determining the interaction of Ibritumomab Intravenous and K-Effervescent Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: potassium bicarbonate
Brand name: Effervescent Potassium, K-Effervescent, K-vescent, K-vescent, K+Care ET, Klor-Con/EF, Effer-K, Quick-K
Synonyms: K-Effervescent
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-K-Lyte/Cl
- Ibritumomab Intravenous-K-Phos M.F.
- Ibritumomab Intravenous-K-Phos Neutral
- Ibritumomab Intravenous-K-Phos No. 2
- Ibritumomab Intravenous-K-Phos Original
- Ibritumomab Intravenous-K-Prime
- K-Effervescent Tablets-Ibritumomab Tiuxetan
- K-Effervescent Tablets-Ibrutinib
- K-Effervescent Tablets-Ibrutinib Capsules
- K-Effervescent Tablets-Ibrutinib Tablets
- K-Effervescent Tablets-Ibu
- K-Effervescent Tablets-IBU Tablets